Both treatments try to raise B12 levels, although their usefulness has been questioned
Yes, for most research applications, 1mg per administration is considered to be on the higher end of the dosing spectrum
Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial
The funders listed above had no role in the design and conduct of the study
While Retatrutide is in Phase 3 clinical trials and not yet FDA-approved in the US, Canadian researchers can access it through domestic research peptide suppliers
Hepatic Lipid Homeostasis and MASH Models: Tracking alterations in liver tissue, specifically focusing on the down-regulation of intrahepatic lipid accumulation and modifications to metabolic pathways associated with metabolic dysfunction-associated steatohepatitis